Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP428134.RA2w_eZRHW7tTg4UbkJe74WeOpOqCdlkeB51UJz_NOeSk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP428134.RA2w_eZRHW7tTg4UbkJe74WeOpOqCdlkeB51UJz_NOeSk130_assertion type Assertion NP428134.RA2w_eZRHW7tTg4UbkJe74WeOpOqCdlkeB51UJz_NOeSk130_head.
- NP428134.RA2w_eZRHW7tTg4UbkJe74WeOpOqCdlkeB51UJz_NOeSk130_assertion description "[Subtle differences in the effects of these different mutations on the many activities of TFIIH and on its stability determine the clinical outcomes, which can be XP, TTD, XP with CS, XP with TTD or COFS.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP428134.RA2w_eZRHW7tTg4UbkJe74WeOpOqCdlkeB51UJz_NOeSk130_provenance.
- NP428134.RA2w_eZRHW7tTg4UbkJe74WeOpOqCdlkeB51UJz_NOeSk130_assertion evidence source_evidence_literature NP428134.RA2w_eZRHW7tTg4UbkJe74WeOpOqCdlkeB51UJz_NOeSk130_provenance.
- NP428134.RA2w_eZRHW7tTg4UbkJe74WeOpOqCdlkeB51UJz_NOeSk130_assertion SIO_000772 14726016 NP428134.RA2w_eZRHW7tTg4UbkJe74WeOpOqCdlkeB51UJz_NOeSk130_provenance.
- NP428134.RA2w_eZRHW7tTg4UbkJe74WeOpOqCdlkeB51UJz_NOeSk130_assertion wasDerivedFrom befree-2016 NP428134.RA2w_eZRHW7tTg4UbkJe74WeOpOqCdlkeB51UJz_NOeSk130_provenance.
- NP428134.RA2w_eZRHW7tTg4UbkJe74WeOpOqCdlkeB51UJz_NOeSk130_assertion wasGeneratedBy ECO_0000203 NP428134.RA2w_eZRHW7tTg4UbkJe74WeOpOqCdlkeB51UJz_NOeSk130_provenance.